Cleerly
The Cloud Security Engineer will lead the design, build, and security of cloud infrastructure, establishing robust architecture standards and implementing infrastructure-as-code security controls. This role involves maintaining cloud security posture, executing core security functions, and acting as a technical expert in architecting secure, scalable cloud systems. The position requires collaboration with engineering and security leadership to embed automated security controls into CI/CD pipelines and ensure continuous compliance with regulatory frameworks.
Headquarters
Denver, Colorado, United States
Company Size
51-200 employees
Founded
2017
Cleerly is a health‑tech company that uses advanced image analysis and AI to deliver personalized assessment and treatment guidance for coronary artery disease. Their software performs a non‑invasive, whole‑heart analysis of coronary CT angiography to identify, characterize, and quantify plaque buildup and stratify risk of heart attack. Cleerly visualizes disease burden and progression for clinicians, supports data‑driven treatment decisions, and integrates into clinical workflows to help hospitals and cardiology teams tailor preventive and interventional strategies.
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
Jan 6, 2026
Cleerly Unveils PowerScribe Integration and Lesion-Level Reporting at RSNA 2025
Nov 26, 2025
Cleerly Raises $106 Million in Funding Led by Insight Partners to Revolutionize Heart Disease Care
Dec 4, 2024
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cleerly.
Right around the average for this role
Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease
Feb 13, 2024